Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compound and method for treating myotonic dystrophy

Compound and method for treating myotonic dystrophy

US Patent 10927378 · Granted Feb 23, 2021

Estimated economic value: $108,783,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bicyclic peptide oligonucleotide conjugates2025
Exon skipping oligomer conjugates for muscular dystrophy2025
Chimeric peptides for antisense delivery2025
Peptide oligonucleotide conjugates2025
Trimeric peptides for antisense delivery2024
Cell-penetrating peptides for antisense delivery2024
Modified antisense oligomers for exon inclusion in spinal muscular atrophy2024
Oligonucleotide analogues targeting human LMNA2023
Peptide oligonucleotide conjugates2023
Peptide oligonucleotide conjugates2023
Oligonucleotides for treating expanded repeat diseases2023
Exon skipping oligomer conjugates for muscular dystrophy2023